Trial NCT01016795

View at ClinicalTrials.gov 
Org. Study IDs: SCF 980266
Secondary IDs: H-KA-99040-GMS

Last trial update was posted on 2015-06-25

MeSH Interventions

Lenograstim

MeSH Conditions

Lymphoma

Other Conditions

Malignant Lymphoma

Stopping Reasons

Study closed Nov 2000 by Amgen, who stopped drug delivery

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID